Inventor · disambiguated record
Jonathan Brazaitis
Also filed as: BRAZAITIS JONATHAN
9 granted patents·2 pending applications·75 citations·filing 2011–2017
84Inventor score
Top patents by PatentIndex Score
11 records- 0195US8946150B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2012·Granted Feb 3, 2015·34 cites·17 claims
- 0294US9169292B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2013·Granted Oct 27, 2015·34 cites·5 claims
- 0386US9605027B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2015·Granted Mar 28, 2017·6 cites·13 claims
- 0474US9868776B2Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2015·Granted Jan 16, 2018·1 cites·9 claims
- 0564US9187750B2Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2013·Granted Nov 17, 2015·0 cites·12 claims
- 0662US10416172B2Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signalingGALLAGHER GRANT·Filed 2011·Granted Sep 17, 2019·0 cites·14 claims
- 0760US2017038396A1ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 ReceptorMEDICAL DIAGNOSTIC LABORATORIES LLC·Filed 2016·Application pending·0 cites
- 0858US2013183755A1Therapeutic application of isolated naturally-occurring soluble truncated forms of il-23 receptorGALLAGHER GRANT·Filed 2013·Application pending·0 cites
- 0957US8618070B2Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2011·Granted Dec 31, 2013·0 cites·4 claims
- 1055US9523073B2Elisa for a naturally-occurring soluble truncated form of IL-23 receptorGALLAGHER GRANT·Filed 2011·Granted Dec 20, 2016·0 cites·12 claims
- 1151USRE49026EPolypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofMEDICAL DIAGNOSTIC LABORATORIES LLC·Filed 2017·Granted Apr 12, 2022·0 cites·36 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →